All In Biotech

Drugs by condition

Drugs approved for neuropathic pain

Brand-name prescription drugs and biologics whose FDA label lists neuropathic pain as an approved use. Matched on the label phrases: "neuropathic pain", "postherpetic neuralgia", "diabetic peripheral neuropathy".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

12

Still marketed, NDA or BLA

Drug classes

1

Novel drugs

4

New molecular entities and new biologics

In development

12

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for neuropathic pain.

  • Drizalma Sprinkle (Duloxetine Hydrochloride) · Sun Pharm Jul 19, 2019
  • Lyrica Cr (Pregabalin) · Upjohn Oct 11, 2017
  • Nucynta Er (Tapentadol Hydrochloride) · Collegium Pharm INC Aug 25, 2011
  • Horizant (Gabapentin Enacarbil) · Azurity NovelOrphanApr 6, 2011
  • Gralise (Gabapentin) · Almatica OrphanJan 28, 2011

All approved drugs for neuropathic pain, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Class not listed in FDA's data (12)

  • Horizant Gabapentin Enacarbil · Azurity · 2011
  • Qutenza Capsaicin · Averitas · 2009
  • Lyrica Pregabalin · Upjohn · 2004
  • Neurontin Gabapentin · Viatris · 1993
  • Drizalma Sprinkle Duloxetine Hydrochloride · Sun Pharm · 2019
  • Lyrica Cr Pregabalin · Upjohn · 2017
  • Nucynta Er Tapentadol Hydrochloride · Collegium Pharm INC · 2011
  • Gralise Gabapentin · Almatica · 2011
  • Lyrica Pregabalin · Upjohn · 2010
  • Neurontin Gabapentin · Viatris · 2000
  • Neurontin Gabapentin · Viatris · 1998
  • Duraclon Clonidine Hydrochloride · Mylan Institutional · 1996

Drugs in development for neuropathic pain

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CagriSemaCagrilintide B and Semaglutide IPhase 36 trials

    Novo Nordisk · Obesity, Diabetes Mellitus, Type 2, Hypertension

  • HL-1186Phase 36 trials

    Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. · Postoperative Pain, Moderate to Severe Acute Postoperative Pain, Postherpetic Neuralgia ( PHN )

  • matched to PregabalinPhase 32 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain

  • matched to SUZPhase 32 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain

  • YJ001Phase 32 trials

    Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. · Diabetic Peripheral Neuropathic Pain (DPNP)

  • HSK16149Phase 31 trial

    Haisco Pharmaceutical Group Co., Ltd. · Central Neuropathic Pain

  • ONO-1110Phase 25 trials

    Ono Pharmaceutical Co., Ltd. · Fibromyalgia, Social Anxiety Disorder (SAD), Major Depressive Disorder (MDD

  • LY4065967Phase 23 trials

    Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee

  • matched to VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • LY3848575Phase 21 trial

    Eli Lilly · Neuropathic Pain, Distal Sensory Polyneuropathy

  • VMD-3866Phase 21 trial

    VM Therapeutics LLC · Chemotherapy-induced Peripheral Neuropathy, Chemotherapy-induced Neuropathic Pain, CIPN - Chemotherapy-Induced Peripheral Neuropathy

More on neuropathic pain: recruiting trials · published research

Related in pain and anesthesia: Osteoarthritis · Acute pain

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.